Company Announcements and Press Releases

Novo Nordisk country sites USA Argentina Australia Austria Belgium Brazil Bulgaria Canada Chile China Croatia Czech Republic Denmark Egypt Estonia Finland France Germany Greece Hungary Iraq Ireland Israel Italy Japan Korea (Republic) Latvia Lebanon Lithuania Mexico Netherlands New Zealand Norway Pakistan Poland Portugal Romania Russian Federation Serbia Slovak Republic Slovenia South Africa Spain Sweden Switzerland Syria Taiwan Thailand Turkey Ukraine United Kingdom Other Novo Nordisk sites Changing diabetes DAWN study Hagedorn Research Institute Diabetes4Patients Diabetes Barometer Changing diabetes bus Media prize World diabetes day School challenge Improve Control HRT for HCPs HRT for women HRT congresses & symposia

• News
• Facts about Novo Nordisk
• R&D pipeline
• Download centre
• Diabetes dictionary
• Broadcast room
• Photos
• Subscription
• Victoza® (liraglutide) press room
• Contact

• 
• Print

News

Status regarding Novo Nordisk's holding of own shares (2 June 2009)

Read the full announcement in PDF format

In continuation of the company's announcement dated 29 January 2009 concerning Novo Nordisk's share repurchase programme, and pursuant to Section 29 of the Danish Securities Trading Act, this is to report that as of today, Novo Nordisk A/S (NYSE:NVO) and its wholly-owned affiliates own more than 5% of the total share capital in Novo Nordisk A/S.

Further information:

Media:	Investors:
Elin K Hansen	Mads Veggerby Lausten
Tel: (+45) 4442 3450	Tel: (+45) 4443 7919
ekh@novonordisk.com	mlau@novonordisk.com
	Kasper Roseeuw Poulsen
	Tel: 4442 4471
	krop@novonordisk.com
In North America:	In North America:
Sean Clements	Hans Rommer
Tel: (+1) 609 514 8316	Tel: (+1) 609 919 7937
secl@novonordisk.com	hrmm@novonordisk.com

Company Announcement no 31 / 2009